Efficacy of Daily IV Administration of Dornase Alfa up to 14 Days Post Subarachnoid Hemorrhage on Functional Independence at 6 Months

Clinical trial NCT06723717 · RECRUITING

Trial details

NCT number: NCT06723717
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ruptured Aneurysm of Intracranial Artery SAH (Subarachnoid Hemorrhage)Delayed Cerebral Ischemia

Start date: 2025-09-26
Primary completion: 2028-03-01
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.